Results 151 to 160 of about 17,651 (213)

Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site. [PDF]

Eur J Immunol
van der Haar Àvila I, Lenos K, Lorrain V, Nardini E, Rodríguez E, García-Vallejo JJ, van Kooyk Y, Grootjans J, van Vliet SJ.   +8 more
europepmc   +1 more source

Protecting the sugar coat on anti-tumor T cells to conceal destruction by tumor microenvironmental landmines. [PDF]

Mol Ther Oncol
Lau LS, Dimitroff CJ.
europepmc   +1 more source

Aberrant glycosylation in hematologic malignancies: mechanisms, immune evasion, and therapeutic targeting. [PDF]

Blood Cancer J
Lu X, Song Z, Wang C, Pan B, Xu Z, Wang Z, Wang H, Wang X, Tang B.   +8 more
europepmc   +1 more source

Glycosylation profile of <i>Mycobacterium leprae</i>-specific antibodies associated with disseminated infection. [PDF]

iScience
van Hooij A, Wang W, Santos de Macedo C, Nouta J, Gijze S, Pinheiro RO, van Hees CLM, Wuhrer M, Geluk A.   +8 more
europepmc   +1 more source

New green strategies for labelling of glycoprotein <i>N</i>-glycans. [PDF]

RSC Adv
Harlin E, Byrne F, Elmes RBP, O'Flaherty R.   +3 more
europepmc   +1 more source

<i>Mycobacterium tuberculosis</i> infection drives osteoclast overactivation via α2,3-Sialylation to promote pathological bone destruction. [PDF]

Front Pharmacol
Jiang Z, Zhang Z, Zhang D, Yu Q, Deng J, Qu Y, Yang Y, Zhang Z, Guo S, Zhang J, Dou C, Luo F.   +11 more
europepmc   +1 more source

Immunoglobulin G in aging and cancer. [PDF]

Front Immunol
Bu M, Li Z, Jones E, Lubaba U, Liu X, Li H.   +5 more
europepmc   +1 more source

Targeting the Sialic acid/Siglec axis: opportunities and challenges in colorectal cancer immunotherapy. [PDF]

J Immunother Cancer
Wang T, Rong C, Sun G, Wang Y.
europepmc   +1 more source

Total Chemical Synthesis of the Human Milk Oligosaccharide Disialyllacto-<i>N</i>-tetraose and Its Degradation by <i>Bifidobacterium bifidum</i> Sialidases. [PDF]

Org Lett
Tanase M, Nakajima A, Komura N, Tanaka H, Ando H, Ishida H, Katayama T, Katoh T, Imamura A.   +8 more
europepmc   +1 more source